Consolidated Balance Sheets - USD ($)	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 1,231,164	$ 927,468
Cash, restricted	0	507,517
Accounts receivable, net	5,303,526	5,300,190
Inventory, net	3,128,986	3,473,604
Other current assets	95,500	144,143
Assets held-for-sale - discontinued operations	0	6,144,793
Current assets - discontinued operations	17,281	281,699
Total current assets	9,776,457	16,779,414
Property and equipment, net	1,265,742	1,273,310
Right of use assets - operating leases, net	443,493	512,389
Right of use assets - finance leases, net	51,711	205,340
Amortizable intangible assets, net	316,480	338,059
Indefinite-lived intangible assets	217,000	217,000
Other noncurrent assets	40,000	40,000
Noncurrent assets - discontinued operations	0	215,509
Total assets	12,110,883	19,581,021
Current liabilities
Accounts payable and accrued liabilities	2,824,850	3,035,799
Accrued separation costs - related parties, current portion	19,759	109,236
Stock appreciation rights liability	733	16,143
Notes payable, current portion	67,022	66,026
Lease liability - operating leases, current	294,679	285,534
Lease liability - finance leases, current	23,427	48,866
Current liabilities - discontinued operations	20,771	8,877,624
Total current liabilities	3,251,241	12,439,228
Note payable non-current, net of discount	199,633	216,947
Accrued separation costs - related parties, non-current	400,000	400,000
Lease liability - operating leases, non-current	158,659	234,963
Lease liability - finance leases, non-current	0	52,683
Total liabilities	4,009,533	13,343,821
Commitments & Contingencies (see note 20)	0	0
Stockholders' equity
Common stock: $0.0001 par value; 500,000,000 shares authorized; 57,493,776 shares issued, and 54,649,479 shares outstanding at March 31, 2026 and December 31, 2025, respectively	5,746	5,746
Additional paid-in capital	45,671,776	45,647,902
Treasury stock: 2,644,297 shares outstanding at March 31, 2026 and December 31, 2025	(1,141,372)	(1,141,372)
Accumulated deficit	(36,434,800)	(38,275,076)
Total stockholders' equity	8,101,350	6,237,200
Total liabilities and stockholders' equity	$ 12,110,883	$ 19,581,021

Liability arising from stock appreciation rights.

No definition available.

Name:	ivfh_StockAppreciationRightsLiability
Namespace Prefix:	ivfh_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.